Yuichiro Ohe

机构：National Cancer Center Hospital East

发表论文 48 篇 · 总被引 416 次 · h-index 11

代表论文

• Comparison of platinum combination chemotherapy plus pembrolizumab versus platinum combination chemotherapy plus nivolumab–ipilimumab for treatment-naive advanced non-small-cell lung cancer in Japan (JCOG2007): an open-label, multicentre, randomised, phase 3 trial (2024 · The Lancet Respiratory Medicine · 被引 43)
• Amivantamab Plus Lazertinib in Patients With EGFR-Mutant NSCLC After Progression on Osimertinib and Platinum-Based Chemotherapy: Results From CHRYSALIS-2 Cohort A (2025 · Journal of Thoracic Oncology · 被引 32)
• Multi-omics and clustering analyses reveal the mechanisms underlying unmet needs for patients with lung adenocarcinoma and identify potential therapeutic targets (2024 · Molecular Cancer · 被引 13)
• Real-world outcomes of treatment strategy between first-line osimertinib, first/second-generation EGFR-TKIs followed by osimertinib and without osimertinib in advanced EGFR-mutant NSCLC (2024 · ESMO Real World Data and Digital Oncology · 被引 11)
• Association between lorlatinib blood concentration and adverse events and clinical impact of dose modification (2024 · Lung Cancer · 被引 10)
• EGFR , TP53 , and CUL3 Triple Mutation in Non‐Small Cell Lung Cancer and its Potentially Poor Prognosis: A Case Report and Database Analysis (2024 · Thoracic Cancer · 被引 4)